ETHNOPHARMACOLOGICAL RELEVANCE: The plant, Vismia rubescens (Guttiferae) is popularly used in Cameroon and in several parts of Africa as febrifugal and for the treatment of various microbial infections (skin diseases, diarrhoea and venereal diseases). AIM OF THE STUDY: This study was mapped out to evaluate the antimicrobial activities of the methanol extract and compounds from the stem bark of Vismia rubescens. MATERIALS AND METHODS: Structures of the compounds obtained after column chromatography of the methanol-soluble fraction were determined by spectroscopy and in comparison with published data. The broth micro-dilution method was used to evaluate the antimicrobial activities against three bacteria species (Salmonella typhi, Staphylococcus aureus and Pseudomonas aeruginosa) and four yeast species (Candida albicans, Candida tropicalis, Candida parapsilosis and Cryptococcus neoformans). RESULTS: Chemical analysis of the methanol extract from the stem bark of Vismia rubescens yielded five known compounds 1,4,8-trihydroxyxanthone (1), 1,7-dihydroxyxanthone (2), physcion (3), friedelin (4) and friedelanol (5). The crude extract and compounds 1, 2 and 3 exhibited both antibacterial and antifungal activities that varied between the microbial species (MIC=3.12-1000 microg/ml). Compounds 2 and 3 were the most active (MIC=3.12-100 microg/ml) while Staphylococcus aureus and Pseudomonas aeruginosa were sensitive to all the tested compounds. The antimicrobial activity of this plant as well as that of compounds 1 and 2 is being reported here for the first time. CONCLUSION: These results provide promising baseline information for the potential use of this plant as well as some of the isolated compounds in the treatment of skin diseases and diarrhoea.
ETHNOPHARMACOLOGICAL RELEVANCE: The plant, Vismia rubescens (Guttiferae) is popularly used in Cameroon and in several parts of Africa as febrifugal and for the treatment of various microbial infections (skin diseases, diarrhoea and venereal diseases). AIM OF THE STUDY: This study was mapped out to evaluate the antimicrobial activities of the methanol extract and compounds from the stem bark of Vismia rubescens. MATERIALS AND METHODS: Structures of the compounds obtained after column chromatography of the methanol-soluble fraction were determined by spectroscopy and in comparison with published data. The broth micro-dilution method was used to evaluate the antimicrobial activities against three bacteria species (Salmonella typhi, Staphylococcus aureus and Pseudomonas aeruginosa) and four yeast species (Candida albicans, Candida tropicalis, Candida parapsilosis and Cryptococcus neoformans). RESULTS: Chemical analysis of the methanol extract from the stem bark of Vismia rubescens yielded five known compounds 1,4,8-trihydroxyxanthone (1), 1,7-dihydroxyxanthone (2), physcion (3), friedelin (4) and friedelanol (5). The crude extract and compounds 1, 2 and 3 exhibited both antibacterial and antifungal activities that varied between the microbial species (MIC=3.12-1000 microg/ml). Compounds 2 and 3 were the most active (MIC=3.12-100 microg/ml) while Staphylococcus aureus and Pseudomonas aeruginosa were sensitive to all the tested compounds. The antimicrobial activity of this plant as well as that of compounds 1 and 2 is being reported here for the first time. CONCLUSION: These results provide promising baseline information for the potential use of this plant as well as some of the isolated compounds in the treatment of skin diseases and diarrhoea.
Authors: Xiaoping Pan; Haixia Wang; Dongmeng Tong; Chen Wang; Li Sun; Chunjuan Zhao; Yan Li; Lida Zhu; Di Wu Journal: Am J Cancer Res Date: 2016-12-01 Impact factor: 6.166
Authors: Patricia D Tchakam; Paul K Lunga; Théodora K Kowa; Antoine Honoré N Lonfouo; Hippolyte K Wabo; Léon A Tapondjou; Pierre Tane; Jules-Roger Kuiate Journal: BMC Complement Altern Med Date: 2012-08-24 Impact factor: 3.659
Authors: Zulane Lima Sousa; Fernando Faustino de Oliveira; Aline Oliveira da Conceição; Luiz Alberto Mattos Silva; Maria Helena Rossi; Juliana da Silva Santos; João Luciano Andrioli Journal: Ann Clin Microbiol Antimicrob Date: 2012-07-28 Impact factor: 3.944